Pembrolizumab vs Topiramate

## Pembrolizumab vs Topiramate: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Topiramate**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Topiramate**: Multiple mechanisms: Na+ channel block, GABA enhancement, glutamate inhibition.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Topiramate — 21 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Topiramate — C12H21NO8S.

**Molecular Weight**: Pembrolizumab — N/A; Topiramate — 339.3630 g/mol.

**Type**: Pembrolizumab — Antibody; Topiramate — Small molecule.